0008.HK
0008.HK
HK0008011667
PCCW
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 40/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
5/7 Elevated
5 / 7 SRI Price Fluctuation & Beta

Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Moves noticeably less than the broader market (0.4x).

Beta (Market Relation)
0.38x
Defensive
Volatility (5Y p.a.)
19.2% p.a.
5-Year Horizon
Max Drawdown (5Y)
-33.9%
5-Year Horizon
Sharpe Ratio
0.14
Return / Risk
Elevated Risk / Growth: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year β€” β€” β€” -5%
3 Years 20.1% -19.5% 0.48 +12%
5 Years 19.2% -33.9% 0.14 +5.2%
10 Years 18.8% -40.4% -0.07 +1.3%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 2102%.
πŸ”΄ High valuation risk: Avg P/E of 171.1 (Elevated multiple compression risk)
πŸ”΄ Low analyst coverage – higher uncertainty in growth estimates & projections

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
10 ISS Score: 10 / 10
Audit Risk
7 ISS Score: 7 / 10
Board Risk
9 ISS Score: 9 / 10
Short Ratio
-
ende